Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1991-11-20
1993-06-01
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 50, 536 23, 536 2852, 536 2853, A61K 3170
Patent
active
052159701
ABSTRACT:
A compound of the formula ##STR1## wherein the radicals A, X, R.sup.1, R.sup.2 and R.sup.3 are defined as follows: ##STR2## R.sup.2 : H; or R.sup.2 constitutes together with R.sup.3 with a carbon - carbon bond
REFERENCES:
patent: 3116282 (1963-12-01), Hunter
patent: 3775397 (1973-11-01), Etzold et al.
patent: 3817982 (1974-06-01), Verheyden et al.
patent: 4247544 (1981-01-01), Bergstrom et al.
patent: 4267171 (1981-05-01), Bergstrom et al.
patent: 4754026 (1988-06-01), Kawada et al.
patent: 4863906 (1989-09-01), Rahim et al.
Yamaguchi et al., Chem. Pharm. Bull., vol. 34, pp. 1441-1450, (1984).
Chemical Abstracts, vol. 92 (1980), abstract No. 208903d, Vopr. Virusol. 1979, (6), 603-6 (Russ).
Chemical Society. London. Journal. Perkin trans. I, 1978, P. J. Barr et al. "The Synthesis of Nucleosides derived from 5-Ethynyluracil and 5-Ethynylcytosine" see pp. 1263-1267.
Journal of Medicinal Chemistry, vol. 17, No. 3, 1974 T. Kulikowski et al. "5-Alkylpyrimidine Nucleosides. Preparation and Properties of 5-Ethyl-2'-deoxycytidine and Related Nucleosides", see pp. 269-273.
Chemical Abstracts, vol. 102 (1985), abstract No. 7013q, Chem. Pharm. Bull. 1984, 32(4), 1441-1450 (Eng.).
J. Carbohydrates Nucleosides Nucleotides, vol. 5, No. 3, 1978, E. Declerq et al., "Nucleosides analogs with selective antiviral activity", see pp. 187-224.
Suito et al.: Nucleosides & Nucleotides, 1(3), 263-273 (1982): Chemical Conversion of Uridine to 3'-Branched Sugar Nucleosides (Nucleosides and Nucleotides, 42.sup.I.)
Datema Roelf
Johansson Karl N. G.
Kovacs Zsuzanna M. I.
Lindborg Bjorn G.
Oberg Bo F.
Brown Johnnie R.
Medivir AB
Wilson J. Oliver
LandOfFree
Nucleosides and nucleotide analogues, pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleosides and nucleotide analogues, pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleosides and nucleotide analogues, pharmaceutical composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1814519